Willingdon Wealth Management’s Novartis NVS Stock Holding History

Willingdon Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-89	Closed	-$8K	–	360
2019 Q4	$8K	Buy	89 +71	+394%	+$6.37K	﹤0.01%	253
2019 Q3	$2K	Buy	+18	New	+$1.62K	﹤0.01%	359
2018 Q4	–	Sell	-1,173	Closed	-$91K	–	387
2018 Q3	$91K	Buy	1,173 +692	+144%	+$51.2K	0.02%	167
2018 Q2	$33K	Buy	481 +270	+128%	+$18.6K	0.01%	208
2018 Q1	$15K	Buy	211 +55	+35%	+$4.19K	﹤0.01%	237
2017 Q4	$12K	Buy	156 +37	+31%	+$2.79K	﹤0.01%	229
2017 Q3	$9K	Buy	+119	New	+$8.99K	﹤0.01%	228
2014 Q3	–	Sell	-16,097	Closed	-$1.31M	–	90
2014 Q2	$1.31M	Buy	16,097 +1,131	+8%	+$89K	0.9%	48
2014 Q1	$1.14M	Buy	14,966 +1,505	+11%	+$110K	0.8%	51
2013 Q4	$970K	Buy	+13,461	New	+$936K	0.76%	51

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Willingdon Wealth Management's NVS Position: Q1 2020 in Review

Willingdon Wealth Management sold out of Novartis (NVS) in Q1 2020, closing a stake of 89 shares — an estimated $8K sold.

Willingdon Wealth Management first reported a position in NVS in Q4 2013 and held it in 10 quarters. The position peaked at $1.31M in Q2 2014. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2020.

Willingdon Wealth Management reported no remaining Novartis position as of Q1 2020 after selling out during the quarter.
Willingdon Wealth Management sold 89 Novartis shares in Q1 2020, an estimated $8K.
Willingdon Wealth Management first reported a position in Novartis in Q4 2013 and held it in 10 quarters.
Willingdon Wealth Management's Novartis position peaked at $1.31M in Q2 2014.
1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2020.

Based on Willingdon Wealth Management's 13F filing for Q1 2020, filed 21 Apr 2020.